Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Aveanna Healthcare Holdings Inc stock (AVAH) is currently trading at $6.62. Aveanna Healthcare Holdings Inc PE ratio is 6.30. Aveanna Healthcare Holdings Inc PS ratio (Price-to-Sales) is 0.59. Analyst consensus price target for AVAH is $10.05. WallStSmart rates AVAH as Hold.
- AVAH PE ratio analysis and historical PE chart
- AVAH PS ratio (Price-to-Sales) history and trend
- AVAH intrinsic value — DCF, Graham Number, EPV models
- AVAH stock price prediction 2025 2026 2027 2028 2029 2030
- AVAH fair value vs current price
- AVAH insider transactions and insider buying
- Is AVAH undervalued or overvalued?
- Aveanna Healthcare Holdings Inc financial analysis — revenue, earnings, cash flow
- AVAH Piotroski F-Score and Altman Z-Score
- AVAH analyst price target and Smart Rating
Aveanna Healthcare Holdings Inc
📊 No data available
Try selecting a different time range
AVAH Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Aveanna Healthcare Holdings Inc (AVAH)
AVAH trades at a significant discount to its Graham intrinsic value of $49.14, offering a 84% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Aveanna Healthcare Holdings Inc (AVAH) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in return on equity, price/sales, revenue growth. Concerns around price/book. Fundamentals are solid but monitor weak areas for improvement.
Aveanna Healthcare Holdings Inc (AVAH) Key Strengths (5)
Every $100 of shareholder equity generates $62 in profit
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 465.20% year-over-year
90.11% of shares held by major funds and institutions
Strong revenue growth at 27.40% annually
Supporting Valuation Data
Aveanna Healthcare Holdings Inc (AVAH) Areas to Watch (4)
Very expensive at 137.4x book value
Thin operating margins with cost pressures present
Thin profit margins with limited profitability
Small-cap company with higher risk but more growth potential
Aveanna Healthcare Holdings Inc (AVAH) Detailed Analysis Report
Overall Assessment
This company scores 62/100 in our Smart Analysis, earning a C+ grade. Out of 9 metrics analyzed, 5 register as strengths (avg 9.6/10) while 4 fall into concern territory (avg 3.8/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on Return on Equity, Price/Sales, EPS Growth. Valuation metrics including Price/Sales (0.59) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 61.60%. Growth metrics are encouraging with Revenue Growth at 27.40%, EPS Growth at 465.20%.
The Bear Case
The primary concerns are Price/Book, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (137.39) suggest expensive pricing. Profitability pressure is visible in Operating Margin at 11.40%, Profit Margin at 9.25%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Book improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 61.60% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 27.40% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Price/Sales) and negatives (Price/Book, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AVAH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AVAH's Price-to-Sales ratio of 0.59x sits near its historical average of 0.55x (60th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 67% below its historical high of 1.77x set in Jun 2021, and 492% above its historical low of 0.1x in Nov 2022.
Compare AVAH with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Aveanna Healthcare Holdings Inc (AVAH) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
Aveanna Healthcare Holdings Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 2.4B with 27% growth year-over-year. Profit margins are thin at 9.3%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Revenue growing at 27% YoY, reaching 2.4B. This pace significantly outperforms most MEDICAL CARE FACILITIES peers.
ROE of 61.6% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
What to Watch Next
Margin expansion: can Aveanna Healthcare Holdings Inc push profit margins above 15% as the business scales?
Growth sustainability: can Aveanna Healthcare Holdings Inc maintain 27%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 2.08, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Aveanna Healthcare Holdings Inc.
Bottom Line
Aveanna Healthcare Holdings Inc offers an attractive blend of growth (27% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(53 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 2:28:44 PM
About Aveanna Healthcare Holdings Inc(AVAH)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.